Clinical trial
An Investigation of Susceptibility Genes for Rare Cancers in Children by Exome Sequencing
NCT03472807 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Investigation of Susceptibility Genes for Rare Cancers in Children by Exome Sequencing
- Lead sponsor
- University Hospital, Angers
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 13, 2019
- Completion date
- February 22, 2024
- Enrollment
- 169 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
cancer childhood, development delay, predisposition, genetic